1Luo RH, Zhao ZX, Zhou XY, et al. Risk factors for primary liver carcinoma in Chinese population. World J Gastroenterol, 2005,11:5193 - 5198.
2Perz JF, Amstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol, 2006,45 : 529 - 538.
3Zhang JY, Dai M, Wang X, et al.A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol, 1998,27:574 - 578.
4Shiratori Y, Ito Y, Yokosuka O, et al. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.Ann Intern Med,2005,142:105 - 114.
5Kasahara A, Hayashi N, Mochizuki K, et al.Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C.Osaka Liver Disease Study Group. Hepatology, 1998,27 : 1394 - 1402.
6Ikeda K, Marusawa H, Osaki Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.Ann Intern Med, 2007, 146: 649 - 656.
7Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.J Gastroenterol Hepatol,2007,22:669 - 675.
8Bruno S, Crosignani A, Maisonneuve P,et al.Hepatitis C virus genotype lb as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeenyear prospective cohort study. Hepatology, 2007, 46:1350- 1356.
9Lai MS, Hsieh MS, Chiu YH, et al.Type 2 diabetes and hepatocellalar carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology, 2006, 43 : 1295 - 1302.
10Pekow JR, Bhan AK, Zheng H, et al.Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer.2007, 109:2490-2496.
2Me! K, Rishma S, Kingsley G, et al. Evaluation of the Core Antigen Assay as a Second-Line Supplemental Test for Diagnosis of Active Hepatitis C Virus Infection[J]. J Clin Microbiol, 2004, 42(9): 4054-4059.
3HD Daniel, P Vivekanandan, S Raghuraman, et al. Significance of the hepatitis C virus(HCV) core antigen as an alternative plasma marker of active HCV infection[J]. Indian J Med Microbiol, 2007, 25(1): 37-42.
4F Ansaldi, G Icardi. Simultaneous detection of anti-HCV antibody and HCV core antigen [J]. Methods Mol Biol, 2009, 510(1): 15-23.
5Syria L, Nadine Le M, Annie G, et al. Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection [J]. J Clin Microbiol, 2005, 43(8): 3877-3883.
6A Schnuriger, S Dominguez, MA Valantin, et al. Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals[J]. J Clin Microbiol, 2006, 44(4): 1561-1563.
